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Abstract
Gill disease of farmed Atlantic salmon (Salmo salar) in the marine environment
has emerged as a significant problem for the salmon aquaculture industry. Differ-
ent types of marine salmon gill disease reported include amoebic gill disease
(AGD), parasitic gill disease, viral gill disease, bacterial gill disease, zooplankton
(cnidarian nematocyst)-associated gill disease, harmful algal gill disease and
chemical/toxin-associated gill disease. The term ‘multifactorial gill disease’ is used
when multiple distinguishable types of disease (as opposed to an obvious single
primary type) are present. When gill disease is non-specific, it is referred to as
‘complex gill disease’ (CGD) or ‘complex gill disorder’. These two terms are often
used interchangeably and are overlapping. The significance of many infectious
and non-infectious agents that may be associated with CGD is often unclear. In
this review, we summarise aspects of the different types of gill disease that are rel-
evant to the epidemiology of gill disease and of CGD in particular. We also tabu-
late simultaneously occurring putative pathogens to explore the multifactorial
nature of gill disease.
Key words: Atlantic salmon, complex gill disease (CGD), marine gill disease, proliferative gill dis-
ease (PGD), proliferative gill inflammation (PGI).
Introduction
Gill disease of farmed Atlantic salmon (Salmo salar) refers
to conditions in which gill pathologies are observed.
Affected fish may display clinical signs of compromised res-
piratory function, and mortality rates may be increased
(Mitchell & Rodger 2011). In the European salmon-pro-
ducing countries like Norway, Scotland and Ireland, gill
disease of salmon in the marine environment has become
one of the most significant health challenges for the salmon
aquaculture industry (Rodger 2007; Matthews et al. 2013;
Hjeltnes et al. 2017; Scottish Government 2018b).
Marine gill disease in farmed salmon can be classified by
aetiology-based subtypes. There are currently seven distin-
guishable types that refer to infection by one principal cau-
sal agent or insult: (i) amoebic gill disease (AGD), (ii)
parasitic gill disease, (iii) viral gill disease, (iv) bacterial gill
disease, (v) zooplankton (cnidarian nematocyst)-associated
gill disease, (vi) harmful algal gill disease and (vii)
chemical/toxin-associated gill disease (Rodger 2007).
Amoebic gill disease has been categorised separately from
other parasitic gill disease because of its significance and
well described distinctive pathology. These types require
complete investigation for accurate diagnosis, to include
histopathology, clinical signs, history, gross gill observa-
tions, parasitology, water samples and molecular test
results.
When some, or all, of these seven types are observed
simultaneously and there is no obvious primary causal
agent, the subtype is referred to as ‘multifactorial gill dis-
ease, consisting of . . .. (the types of specific gill diseases)’.
When principal pathological changes are non-specific,
either in combination with, or in the absence of, one or
more of the seven distinctive types (including AGD), the
type of gill disease is referred to as ‘complex gill disease
or disorder (CGD)’ (Noguera et al. 2019). The terms
CGD and multifactorial gill disease are often used
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interchangeably and are overlapping. An example of CGD
can be found in Figure 1.
The epidemiology of CGD, particularly regarding the
influence of various pathogens, environmental contributors
and the role of some management practices, is not well
understood. This review is intended to provide an up-to-
date overview of infectious and non-infectious agents
involved with gill disease, with a particular focus on factors
relevant to the investigation of the epidemiology of gill dis-
ease in general, and CGD more specifically, in farmed
Atlantic salmon. We provide an overview of CGD, and sep-
arately the seven types of gill disease listed above to provide
as much distinction as possible, though these types may
often occur simultaneously in multifactorial or complex gill
disease cases. Where known, we have included descriptions
and nomenclature of pathogens/agents putatively associ-
ated with gill disease, the effects of the pathogens/agents,
information on the temporal and geographical distribution
of forms of gill disease, clinical signs of disease, risk factors
for disease, treatment options and a selection of additional
reviews for further information. We have also tabulated the
simultaneously occurring agents and pathogens to review
the multifactorial-aspect of gill disease.
Complex gill disease and related syndromes
Complex gill disease encompasses syndromes referred to as
‘proliferative gill inflammation’ (PGI) and ‘proliferative gill
disease’ (PGD; Herrero et al. 2018). PGI is a pathology-
based diagnosis first described in Norway, in which gills
present a combination of the following four histopathologi-
cal changes: lamellar vascular changes, inflammation, cell
death and epithelial cell hyperplasia (Kvellestad et al. 2005).
In addition to these histopathological changes, additional
signs include grossly pale gills, increased mucus and the
presence of epitheliocysts in gill tissue (Steinum et al. 2010;
Nylund et al. 2011). PGI has been present since at least the
1980s in Norway (Kvellestad et al. 2005).
In Scotland and Ireland, gill conditions similar to PGI
have been reported (Mitchell & Rodger 2011; Rodger &
Mitchell 2013) which have been called PGD in the past
(Matthews et al. 2013). PGD has been used as a non-speci-
fic term derived from examination of gross lesions in the
salmon gill in the field (Herrero et al. 2018), and also as a
general descriptive term for gill disorders that include pro-
liferative changes in the gill epithelium (Nylund et al.
2008). The term ‘proliferative gill disease’ is also used for
specific conditions in other species, for example, the lead-
ing parasitic disease for farm-raised channel catfish (Ictalu-
rus punctatus) in the United States of America (Bosworth
et al. 2003; Beecham et al. 2010). CGD is increasingly com-
monly diagnosed in Atlantic salmon where proliferative-
type gill disease is observed associated with exposure to one
or more agents. Because CGD encompasses PGI and PGD,
but is an emerging term, we have included information on
PGI and PGD in this ‘complex gill disease’ part of the
review where appropriate.
Proliferative-type gill disease in salmon can result in ele-
vated mortality rates, reduced growth rates, runting and
reduced food conversion efficiency (Kvellestad et al. 2005;
Rodger et al. 2011b). PGI affects farmed salmon during the
seawater production phase (Kvellestad et al. 2005; Steinum
et al. 2009). It remains to be conclusively shown whether
there is an association between gill disease in the marine
environment and prior experiences encountered by salmon
during the freshwater phase of production. Examples of
putative pathogens that are encountered in both environ-
ments are Candidatus Clavochlamydia salmonicola (Mitch-
ell et al. 2010), described in the bacterial gill disease section
and salmon gill pox virus (Gjessing et al. 2017), described
in the viral gill disease section.
The aetiology of CGD is unclear. The non-specific
pathology may be a chronic end-stage pathology following
insult(s) and challenge(s) or a cascade of such events
(Gjessing et al. 2017). A number of putative pathogens have
been detected in proliferative-type gill disease (Table 1).
The significance of many of the agents and insults remains
to be determined (Mitchell & Rodger 2011; Rodger et al.
2011a; Herrero et al. 2018), such as those associated with
the formation of epitheliocysts (Kvellestad et al. 2005; Stei-
num et al. 2008, 2009, 2010; Mitchell et al. 2013). Other
unidentified bacteria have also been detected in salmon
with gill disease (Steinum et al. 2009). Parasites detected in
cases of gill disease include Neoparamoeba perurans
(Nylund et al. 2008, 2011; Steinum et al. 2008; Gjessing
et al. 2019), Desmozoon lepeophtherii (Steinum et al. 2010;
Nylund et al. 2011; Matthews et al. 2013; Gjessing et al.
2019), Ichthyobodo spp. (Kvellestad et al. 2005; Nylund
Figure 1 An example of complex gill disease (CGD) lesions in Atlantic
salmon.
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et al. 2011), Trichodina (Kvellestad et al. 2005; Nylund et al.
2011; Mitchell et al. 2013), Parvicapsula pseudobranchicola
(Nylund et al. 2011) and others (Nylund et al. 2011).
Detected viruses include Atlantic salmon paramyxovirus
(ASPV) (Kvellestad et al. 2005; Steinum et al. 2010), sal-
mon gill poxvirus (SGPV) (Nylund et al. 2008, 2011; Gjess-
ing et al. 2017; Gjessing et al. 2019) and salmon alphavirus
(SAV) (Nylund et al. 2011). For reviews of infectious and
non-infectious agents that can affect salmonid gills, see
Mitchell and Rodger (2011) and Rodger et al. (2011a).
Often, multiple putative pathogens occur simultaneously
in CGD cases, which are shown in Table 1. Variation in co-
infections makes histopathological diagnosis of CGD highly
complex (Gjessing et al. 2019). The relationship between
CGD and some of the associated pathogens has been
described as dose-dependent, but complex (Steinum et al.
2010; Mitchell et al. 2013; Gunnarsson et al. 2017; Downes
et al. 2018a). For example, epitheliocysts were inconsis-
tently observed in PGI-positive cases (Mitchell et al. 2013)
and were found in lesser quantities in non-PGI cases (Stei-
num et al. 2010), and there were signs of a dose-dependent
relation between severity of PGI cases and epitheliocysts
(Mitchell et al. 2013). This suggests that they are unlikely to
be the primary cause of PGI, but might contribute to the
severity of the condition, or be proliferating opportunisti-
cally as a secondary result of the effects of another patho-
genic agent.
In addition to the presence of putative pathogens, a
number of other potential risk factors for CGD have been
proposed. One major type of risk factor may be environ-
mental insult to the gills, such as exposure to harmful phy-
toplankton, gelatinous zooplankton species in the water
column or biofouling organisms dislodged into pens dur-
ing in situ net washing (Rodger et al. 2011a; Bloecher et al.
2018; Kintner & Brierley 2019). Bath treatments involving
the use of chemotherapeutants such as formalin (Speare
et al. 1997) or hydrogen peroxide (Kiemer & Black 1997;
Rodger et al. 2011a) can be directly damaging to gills or
may exacerbate existing gill conditions and may represent a
risk factor for the development of CGD. Infectious organ-
isms that cause gill pathology, such as the hyperplastic
response of the gill to the presence of N. perurans in AGD
(Adams et al. 2004), can be risk factors. Other factors that
have been suggested to affect incidence and severity of pro-
liferative-type gill disease include salmon genetic strain,
environmental conditions (such as water eutrophication
and pollution), nutritional deficits (reviewed by Rodger
et al. 2011a), concurrent health issues and husbandry prac-
tices, such as use of lice-skirts, frequency of handling and
the use of mechanical delousing systems.
The occurrence of CGD appears to have a seasonal pat-
tern, with signs occurring mainly at the end of summer to
early winter in Norway and Scotland (Kvellestad et al.
2005; Matthews et al. 2013), though there have been cases
in May reported from Norway (Nylund et al. 2011), sum-
mer in Ireland (Rodger et al. 2011b) and as early as March/
April in Scotland (Chris G.G. Matthews, pers. comm.,
2019). In Norway, proliferative-type gill disease mainly
occurs in western Norway (Nylund et al. 2011), which sug-
gests that geographic location may play a role. Within
specific regions, certain sites are perceived to be more
prone than other sites (Chris G.G. Matthews, pers. comm.,
2019).
Treatment strategies that have been used in cases with
CGD include supplemental oxygenation or aeration within
sea pens, treatment with freshwater baths, installation of
short tarpaulin skirts or booms (in an attempt to exclude
surface harmful algae or jellyfish blooms), provision of
functional feeds purported to boost immune function or
promote healing and in rare circumstances a course of oral
broad-spectrum antibiotics (Rodger et al. 2011b). It has
been suggested that vaccination might become a viable
treatment strategy if specific bacteria or viruses can be con-
firmed as playing critical roles in the aetiology of CGD in
farmed Atlantic salmon (Koppang et al. 2015).
Specific types of marine salmonid gill disease
Amoebic gill disease
Arguably, the most significant infectious agent contributing
to proliferative gill diseases of farmed Atlantic salmon glob-
ally is the marine amphizoic amoeba N. perurans, which is
associated with AGD (Crosbie et al. 2012). AGD has
emerged as a distinct and significant health challenge since
2011 in marine salmon farms in Europe. AGD can lead to
high mortalities, reportedly reaching up to 82% (Steinum
et al. 2008) and significant morbidity. Changes occurring in
the gill as a result of infection with N. perurans can lead to
compromised gas exchange and ion regulation across the
gills, potentially affecting appetite, growth and overall sur-
vival (Hvas et al. 2017). AGD has had a large impact on the
aquaculture industry in Tasmania since 1984 (Taylor et al.
2009). The disease has since been reported in Atlantic sal-
mon from all major producing countries (Oldham et al.
2016): Ireland in 1995 (Rodger & McArdle, 1996; Downes
et al. 2018b), Scotland and Norway in 2006 (Steinum et al.
2008; Young et al. 2008), Chile in 2007 (Bustos et al. 2011)
and western Canada in 2016 (ICES, 2016). Species other
than Atlantic salmon can be affected by AGD, such as coho
salmon (Oncorhynchus kisutch), rainbow trout (Oncor-
hynchus mykiss), chinook salmon (Oncorhynchus tsha-
wytscha), turbot (Scophthalmus maximus), ayu (Plecoglossus
altivelis) and halibut (Hippoglossus hippoglossus) (Jansson &
Vennerstrom 2014; Rodger 2019). AGD has also been
found in fish species used as biological parasite control in
farmed Atlantic salmon including lumpsucker (Cyclopterus
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lumpus) and wrasse (Labridae spp) (Oldham et al. 2016;
Haugland et al. 2017; Hellebø et al. 2017).
Neoparamoeba perurans is also referred to as Paramoeba
perurans (Young et al. 2008; Nowak & Archibald, 2018). It
has been suggested that Paramoeba and Neoparamoeba
should be merged into a single genus prioritising the name
Paramoeba (Feehan et al. 2013), but this has not been com-
monly accepted because taxonomic conclusions were based
on single-gene trees with low number of Paramoebidae
(Young et al. 2014; Volkova & Kudryavtsev, 2017). Other
amoeba, including P. branchiphila, P. pemaquidensis/
N. pemaquidensis and Nolandella spp., have been observed
from gills of fish with AGD using culture and PCR tech-
niques. In these studies, N. perurans appeared to be the pri-
mary pathogen, and the role of the other amoeba remained
unclear (Kent et al. 1988; Dykova & Novoa, 2001; Morrison
et al. 2005; Vincent et al. 2007; English et al. 2019a; English
et al. 2019b).
The first observed clinical signs of AGD are often a
reduction in appetite, lethargy and altered swimming beha-
viour such as fish swimming close to the surface. As disease
progresses, clinical signs observed can include respiratory
distress, progressing to death of affected individuals in sev-
ere cases. Gross gill appearance includes multifocal pale
lesions on the gill surface or raised white mucoid spots and
plaques (Adams et al. 2004), as shown in Figure 2.
Several systems have been developed to score AGD sever-
ity based on gross observations of gills of anaesthetised fish.
Adams et al. (2004) use a system with scores 0–3 based on
number of effected hemibranchs. Adams and Nowak
(2004) use the terms ‘clear’, ‘faint spots’, ‘spots’ and
‘patches’ based on translucent appearance and quantity of
spots. A system of scores 0–5 based on white patches or
scarring and percentage gill coverage, used by Taylor et al.
(2009), has been commonly adopted by industry in Norway
(Hellebø et al. 2017) and other European countries.
Presumptive diagnosis of AGD is based on clinical signs
and the microscopic observation of typical amoebae on wet
gill smears. The presence of N. perurans can be confirmed
using polymerase chain reaction (PCR), which does not
require the destruction of the fish host (Downes et al. 2017,
2018b), or destructively by histology, in which observed
abnormalities are epithelial hyperplasia, lamellar fusion,
inflammation, cell death, presence of interlamellar vesicles
and presence of amoeba (Adams et al. 2004; Mitchell &
Rodger, 2011).
Environmental risk factors for AGD are high salinity
(Clark & Nowak, 1999), proximity to an infected site and
elevated temperatures (Douglas-Helders et al. 2001).
Described husbandry risk factors include high stocking
density (Crosbie et al. 2010) and local crowding, which can
be five times the stocking density at times and might be
reduced by the use of lights (Wright et al. 2015, 2017).
Biofouling, which are the diverse assemblage of flora and
fauna formed by successive growth of organisms on solid
surfaces exposed to the marine environment (Tan et al.
2002) may be a risk factor for AGD, (Tan et al. 2002).
However in another study, biofouling did not affect AGD
prevalence, but fewer net changes, which could mean more
growth of biofouling on nets, was a risk factor (Clark &
Nowak 1999). Microbial dysbiosis, which is disturbance or
imbalance of the microbiome, may also contribute to AGD
(Nowak & Archibald 2018).
The genetics of fish stocks can also affect AGD. Hybrid
fish such as Atlantic salmon x brown trout (Salmo trutta)
have been shown to be more resistant to AGD. Further-
more, genetic selection can reduce the number of AGD
treatments needed (Taylor et al. 2014; Maynard et al.
2016).
Cleaner fish (i.e. fish of other species cohabited with sal-
mon to remove sea lice) of the species Cyclopterus lumpus
and Labrus bergylta (or ballan wrasse) can develop AGD
from N. perurans (Karlsbakk et al. 2013; H. Rodger in Old-
ham et al. (2016)). It was suggested that cleaner fish are
more tolerant to N. perurans with a slower developing
pathology compared with Atlantic salmon and may there-
fore act as a carriers, transmitting the amoeba to salmon
(Haugland et al. 2017).
Freshwater bathing is the main treatment of choice
against AGD. It has to be repeatedly applied, because it alle-
viates but does not eliminate AGD (Parsons et al. 2001;
Clark et al. 2003), at least in part due to the continued pres-
ence of amoebae in the environment. Disadvantages of this
method include its labour intensity and its expense. The
treatment has been reported to remove 86% of live amoeba
(Clark et al. 2003), but can be variable, which might be
due, for example, to hardness and chemical composition of
the freshwater used (Powell et al. 2015). Other treatments,
such as the use of hydrogen peroxide, are being applied or
developed (Powell et al. 2015). There is some evidence of
resistance of Atlantic salmon against repeated infestations
by N. perurans (Vincent et al. 2006; Taylor et al. 2009), but
an effective vaccine has not been developed (Valdenegro-
Vega et al. 2015). Restricting or minimising movement of
fish and overall good hygienic standards have been recom-
mended as preventive measures.
Amoebic gill disease has been detected in CGD, PGD
and PGI cases (Nylund et al. 2008, 2011; Steinum et al.
2008; Gjessing et al. 2019). It has been detected simultane-
ously with the parasites D. lepeophtherii (Steinum et al.
2015; Downes et al. 2018a; Gjessing et al. 2019), and Tri-
chodina sp. (Rodger & McArdle 1996; Rodger et al. 2011b)
and Scuticociliatia (Dykova et al. 2010). It has also been
found alongside salmon gill pox virus (SGPV; Nylund et al.
2008; Gjessing et al. 2015, 2017, 2019; Hvas et al. 2017;
Downes et al. 2018a) and damage due to the jellyfish
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Pelagia noctiluca (Marcos-Lopez et al. 2016). It has been
observed simultaneously with epitheliocysts (Gjessing et al.
2017) and the associated bacteria Ca. Piscichlamydia sal-
monis (Steinum et al. 2015; Gjessing et al. 2019), Ca. Bran-
chiomonas cysticola (Steinum et al. 2015; Gjessing et al.
2017, 2019; Downes et al. 2018a) and Ca. Sygnamidia sal-
monis (Nylund et al. 2018). AGD has been detected simul-
taneously with Yersina ruckeri (Valdenegro-Vega et al.
2014) and Tenacibaculum maritimum (Powell et al. 2005;
Rodger et al. 2011b; Downes et al. 2018a). However, in an
experimental trial involving AGD-affected fish which were
subsequently infected with T. maritimum, no evidence of
interaction (e.g. predisposal) was observed (Powell et al.
2005). AGD has also been detected simultaneous to other
or non-specified bacteria species (Adams et al. 2004). See
Table 1 for an overview.
Reviews that focus on AGD include Mitchell and Rodger
(2011) and Oldham et al. (2016).
Other forms of parasitic gill disease
Apart from amoeba, many other parasite species have been
identified in marine salmon gills diagnosed with CGD or
proliferative-type gill disease, as shown in Table 1. The par-
asites described here are putative pathogens sometimes
associated with CGD.
Desmozoon lepeophtherii (syn. Paranucleospora theridion)
Desmozoon lepeophtherii, less frequently referred to as
Paranucleospora theridion (Freeman & Sommerville, 2011),
is a microsporidian that was discovered in sea lice in Scot-
land in 2000 (Freeman 2002). It has since been reported
from Norway (Nylund et al. 2010), Ireland (Ruane et al.
2013) and the Pacific coast of North America (Jones et al.
2012). Desmozoon lepeophtherii may have been present for
much longer in these populations: it has recently been iden-
tified, for example, in samples collected in 1995 in Ireland
(Downes et al. 2018b). In salmon, the parasite infects dif-
ferent cell types such as gill and skin epithelial cells, blood
vessel endothelial cells, polymorphonuclear leucocytes and
macrophage-like cells (Nylund et al. 2010; Weli et al. 2017).
The transmission route of the parasite has not been fully
elucidated, but it has been suggested that the microsporid-
ian spores possibly infect the salmon gills first and then
spreads to other tissues and organs (Nylund et al. 2010;
Sveen et al. 2012). It is likely that the sea lice would ingest
the parasite spores whilst feeding on the epithelial cells of
the skin of infected salmon (Sveen et al. 2012). The sea lice
may not be essential for infection of salmon (Sveen et al.
2012).
Desmozoon lepeophtherii occurs in apparently healthy
fish, but is reportedly more abundant in diseased or com-
promised fish, such as fish diagnosed with PGI (Steinum
et al. 2010) and fish with a low condition factor (Gun-
narsson et al. 2017). Reports about associations between
disease and D. lepeophtherii are scarce. Matthews et al.
(2013) showed that D. lepeophtherii appeared to be acting
as a causative agent associated with distinct pathology, but
it could not be definitively concluded that D. lepeophtherii
was the true primary pathogen. A dose dependency with
disease was described by Steinum et al. (2010), in which
study higher D. lepeophtherii densities were associated with
PGI fish compared with non-PGI fish. Weli et al. (2017)
describe the progression of D. lepeophtherii disease in a
farm in Norway with severe gill disease, poor growth and
mortalities. It has not been established whether the abun-
dant presence of D. lepeophtherii is causative to pathology.
Histopathological changes observed in gills and attribu-
ted to D. lepeophtherii include hyperplasia and hypertrophy
associated with presence of developmental stages or the
degeneration of D. lepeophtherii (Nylund et al. 2011). An
initial acute pathology in gills is necrosis and can be a direct
result of D. lepeophtherii, but the chronic proliferative and
inflammatory stage might be a result of a fish host response
(Weli et al. 2017). Fish with high levels of D. lepeophtherii
have also been reported with non-specific histopathological
changes in kidney, spleen, gut, exocrine pancreas, somatic
muscle and heart (Freeman 2002; Nylund et al. 2010,
2011), but it is unknown if those changes are associated
with or due to the presence of D. lepeophtherii. In addition
to histopathology, molecular methods are also used to
detect D. lepeophtherii (Nylund et al. 2010).
Desmozoon lepeophtherii was detected in PGD and PGI
cases (Nylund et al. 2011; Matthews et al. 2013; Steinum
et al. 2015; Gjessing et al. 2019), and in combination with
other pathogens, such as epitheliocysts (Weli et al. 2017)
and associated bacteria (Nylund et al. 2011; Steinum et al.
2015; Downes et al. 2018a; Gjessing et al. 2019). Also,Figure 2 Severe amoebic gill disease (AGD) lesions.
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T. maritimum (Downes et al. 2018a) and other non-speci-
fied bacteria (Weli et al. 2017) were found alongside
D. lepeophtherii. Others are N. perurans (Steinum et al.
2015; Downes et al. 2018a; Gjessing et al. 2019), Trichodina
spp. (Weli et al. 2017) salmonid alphavirus (SAV; Nylund
et al. 2011; Gunnarsson et al. 2017) and salmonid gill pox-
virus (SGPV; Nylund et al. 2011; Downes et al. 2018a;
Gjessing et al. 2019). See Table 1.
There is a paucity of described risk factors for presence
of D. lepeophtherii in salmon gills. As for other
microsporidians, a temperature of about 10°C or higher
may be essential for propagation and the subsequent pro-
duction of spores, in order to establish a systemic infection
(Sveen et al. 2012). Probably due to the effect of tempera-
ture, infection appears to be seasonal. In a study by Gun-
narsson et al. (2017), D. lepeophtherii densities were higher
in salmon sampled in autumn of the first year at sea, com-
pared with other seasons of the first year at sea, and in a
study by Sveen et al. (2012), D. lepeophtherii infections
were similar, but different for fish transferred when the
water temperature was already low as these fish did not
develop systemic infections in their first winter. Another
effect of temperature could be the geographic region, as
D. lepeophtherii infections were more intense and abundant
in Western Norway compared with Northern Norway
(Nylund et al. 2011).
Viral gill disease
Whilst there are a number of viruses that may be detected
in gills, such as salmonid alphavirus (SAV), two viruses in
particular have been associated with marine salmonid gill
disease: Atlantic salmon paramyxovirus (ASPV) and sal-
mon gill pox virus (SGPV).
Atlantic salmon paramyxovirus
Atlantic salmon paramyxovirus (ASPV) was first identified
and described in Norway in 2003 (Kvellestad et al. 2003). It
has been suggested that ASPV might be a contributor for
PGI in conjunction with other pathogens and that the slow
in vitro replication rate of ASPV may explain the long dura-
tion of the PGI outbreaks on fish farms (Kvellestad et al.
2005). However, challenge experiments did not result in
any mortality or pathology (Fridell 2003 in (Nylund et al.
2008)). Another suggested association between ASPV and
disease is that it may cause disease if fish are weakened or
stressed (Fridell 2003), but recent studies have shown an
inconsistent association between the virus and PGI out-
breaks (Steinum et al. 2010; Nylund et al. 2011).
Atlantic salmon paramyxovirus was detected in PGI cases
(Kvellestad et al. 2005; Steinum et al. 2010), and simultane-
ous to epitheliocysts (Kvellestad et al. 2003; Fridell 2003;
Kvellestad et al. 2005), but correlation between ASPV and
epitheliocysts was not expected because none, one, or both
were detected in the same fish (Kvellestad et al. 2005). See
Table 1.
Salmon gill pox virus
Salmon gill pox virus (SGPV) was first reported in Atlantic
salmon at a freshwater site in Norway (Nylund et al. 2006
(in Norwegian) in Nylund et al. (2008)) and has since been
reported from Canada (ICES 2016), Faroe Islands (Nolsøe
et al. (2015) in Gjessing et al. (2016)), Scotland (Rodger,
pers. comm. in Gjessing et al. (2016)) and Ireland using
samples from as early as 1995 (Downes et al. 2018b), in
fresh and salt water. SGPV has also been detected in wild
salmonids (Garseth et al. 2018).
Salmon gill pox virus has been associated with high levels
of acute mortality during the freshwater phase of salmon
growth. Impact of SGPV is reportedly most pronounced
during smoltification (Gjessing et al. 2017) and in fry stages
(Chris G.G. Matthews, pers. comm., 2019). The virus may
be involved with disease during the entire seawater cycle as
well, as it was found 67 weeks after seawater transfer (Dow-
nes et al. 2018a).
A typical histopathological sign of SGPV is apoptosis of
gill epithelial cells, but because this is not always observed.
a molecular test for SGPV is considered essential to reliably
indicate its presence (Gjessing et al. 2017). Some fish that
tested positive by histology and PCR for SGPV had abnor-
malities in spleen, liver, heart and pyloric ceca (Gjessing
et al. 2015). At present, recommendations around control
of SGPV focus on maintaining best practice husbandry and
biosecurity procedures. The effects of an outbreak can be
minimised through cessation of feeding, increasing dis-
solved oxygen levels and avoidance of stress (Gjessing et al.
2016).
Molecular techniques have revealed that SGPV is
widely distributed and occurs often in combination with
other agents, which may mean that it forms part of the
multifactorial pathology of CGD (Gjessing et al. 2017).
However, SGPV has been inconsistently observed in fish
with gill disease (Nylund et al. 2011) and has been
detected from apparently healthy fish (Gjessing et al.
2017). SGPV disrupts the epithelial barrier and compro-
mises innate immunity. In a multifactorial pathology
such as suggested for CGD, SGPV may aid opportunistic
infections by other organisms by facilitating insult, and
it may precede and exacerbate the development of AGD
(Gjessing et al. 2017).
Salmon gill pox virus has been found in fish with CGD,
PGD and PGI (Nylund et al. 2008, 2011; Gjessing et al.
2017; Gjessing et al. 2019). It has also been detected simul-
taneously with epitheliocysts and epitheliocyst-forming
bacteria (Nylund et al. 2008; Gjessing et al. 2017, 2019;
Garseth et al. 2018; Downes et al. 2018a), T. maritimum
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(Downes et al. 2018a) and other unspecified bacteria
(Gjessing et al. 2017; Garseth et al. 2018). Parasites and
fungi detected simultaneously with SGPV include N. peru-
rans (Nylund et al. 2008; Gjessing et al. 2015, 2017, 2019;
Hvas et al. 2017; Downes et al. 2018a), D. lepeophtherii
(Nylund et al. 2011; Downes et al. 2018a; Gjessing et al.
2019), Ichthyobodo spp. (Gjessing et al. 2017; Garseth et al.
2018), Trichodina sp. (Garseth et al. 2018), Saprolegnia sp.
(Gjessing et al. 2017; Garseth et al. 2018), among others
(Garseth et al. 2018). See Table 1.
For a review of fish poxviruses see Gjessing et al. (2016).
Bacterial gill disease
The bacteria described here are associated with prolifera-
tive-type gill diseases in marine salmon. They are generally
considered to be secondary invaders or opportunists.
Epitheliocysts
Epitheliocystis, that is disease due to epitheliocysts, is a
condition in which fish gills, and less commonly skin
epithelial cells, present with cytoplasmic membrane-bound
inclusions (epitheliocysts) which contain bacteria, many of
which remain to be characterised (Mitchell et al. 2013).
The bacteria can be observed late in the infection when
they have formed their characteristic cysts (Kvellestad et al.
2005). Epitheliocystis has been described in over 50 fish
species around the globe, in fresh and salt water (Fryer &
Lannan 1994; Nowak & LaPatra 2006). The discussion
here will be restricted to salmonids and with respect to
CGD.
Epitheliocystis in salmonid gills has been detected in Ire-
land (Downes et al. 2018b), Norway (Draghi et al. 2004;
Mitchell et al. 2013), Scotland (Rodger & Mitchell 2013)
and Tasmania (Nowak & LaPatra 2006). The presence of
epitheliocysts often is not associated with clinical disease in
farmed salmon, as it has been observed in apparently
healthy fish (Mitchell et al. 2010). However, epitheliocysts
have been suspected to play a role in some cases of CGD
where mortality rates reached up to 100% (Nylund et al.
1998). If associated with disease or mortality, the condition
is also referred to as a hyper infection (Nowak & LaPatra
2006). Epitheliocysts are not present in all CGD cases
(Mitchell & Rodger 2011; Matthews et al. 2013).
To date, at least four agents have been identified that lead
to epitheliocystis in Atlantic salmon in Norway and Ireland
in a marine environment: Candidatus Piscichlamydia
salmonis, Ca. Branchiomonas cysticola, Ca. Sygnamidia
salmonis and Ca. Clavochlamydia salmonicola. Sometimes
several of these agents may be detected simultaneously,
for example Ca. Piscichlamydia salmonis and Ca.
Branchiomonas cysticola (Mitchell et al. 2013; Steinum
et al. 2015).
Candidatus Piscichlamydia salmonis, a bacterium identi-
fied from salt- and freshwater, was proposed to have been
responsible for epitheliocystis in marine farmed Atlantic
salmon in Norway and Ireland in 1999 and 2000 (Draghi
et al. 2004). No direct correlation could be found, however,
between the pathogen and gill disease (Steinum et al. 2010;
Mitchell & Rodger 2011). Furthermore, chlamydia-like
organisms might be opportunistic rather than primary
pathogens (Horn 2008), indicating there may be other pri-
mary pathogen(s) or agent(s) involved.
One such possible primary pathogen is the betapro-
teobacterium Ca. Branchiomonas cysticola (Toenshoff
et al. 2012). It has been detected in a wide range of samples
from Norway and Ireland and is considered common in
European salmon aquaculture (Mitchell et al. 2013). The
presence of this organism, which like Ca. Piscichlamydia
salmonis is found in salt- and freshwater salmon (Mitchell
et al. 2013; Wiik-Nielsen et al. 2017), has been shown to be
quantitatively correlated with pathological changes consis-
tent with CGD, but it has also been frequently found in fish
without apparent gill pathology. During freshwater infec-
tion trials, in which the water of infected fish was used as a
source of waterborne infection for a population of na€ıve
juvenile Atlantic salmon, Ca. B. cysticola infections were
associated with gill epithelial cell proliferation and subep-
ithelial inflammation (Wiik-Nielsen et al. 2017). In a study
looking at the histopathology of co-infections in Atlantic
salmon obtained from salt water, necrosis in hyperplastic
lesions, pustules and necrosis of subepithelial cells were
specific changes that appeared to be associated with Ca. B.
cysticola infection (Gjessing et al. 2019). Both these find-
ings suggest that histological lesions other than only the
formation of cysts in the epithelial cells may occur in gills
infected by the bacteria. Unfortunately, the high prevalence
of Ca. B. cysticola in healthy fish has hindered understand-
ing its role in CGD.
A third reported bacterial agent is Ca. Sygnamidia
salmonis. This is another member of the Chlamydiae,
which has been isolated from a farm with fish diagnosed
with gill disease and elevated mortality rates (Nylund et al.
2015). Correlation with the severity of pathology was not
reported, and it is unknown if this organism causes epithe-
liocystis in apparently healthy fish, since only diseased fish
were used in the study. It has been shown capable of repli-
cating in N. perurans (Nylund et al. 2018).
The fourth reported agent is Ca. Clavochlamydia
salmonicola (Karlsen et al. 2008). This is a Chlamydiae
associated with freshwater epitheliocystis. It has not been
shown to be associated with pathological changes such as
epithelial hyperplasia in most fish. A study of the occur-
rence of Ca. Clavochlamydia salmonicola reported that the
agent could no longer be observed 4–6 weeks after fish
were transferred to marine pens (Mitchell et al. 2013).
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Depending on severity of infection, histopathological
changes of gills of fish with epitheliocystis can be consistent
with CGD: these include a proliferative hyperplasia with
hypertrophy, inflammation and necrosis (Nowak & Clark,
1999). Additionally, gills have characteristic cysts, which
can be observed macroscopically in some instances as white
to yellow cysts. Molecular tests have been developed for all
mentioned agents: Ca. P. salmonis (Ruane et al. 2013), Ca.
B. cysticola (Toenshoff et al. 2012; Mitchell et al. 2013), Ca.
S. salmonis (Nylund et al. 2015) and Ca. C. salmonicola
(Mitchell et al. 2010).
Other bacteria that have been detected simultaneously
with epitheliocystis are T. maritimum (Rodger et al.
2011b; Downes et al. 2018a), and unidentified bacteria
(Steinum et al. 2009; Garseth et al. 2018). Co-occurring
parasites include Icthyobodo spp. (Gjessing et al. 2017),
N. perurans (Steinum et al. 2015; Gjessing et al. 2017,
2019; Nylund et al. 2018; Downes et al. 2018a),
D. lepeoptherii (Nylund et al. 2011; Steinum et al. 2015;
Weli et al. 2017; Downes et al. 2018a; Gjessing et al.
2019) and Trichodina spp. (Garseth et al. 2018). Viruses
that have been simultaneously detected with epitheliocys-
tis include ASPV (Kvellestad et al. 2003; Fridell 2003;
Kvellestad et al. 2005), though there was no correlation
observed (Kvellestad et al. 2005); and SGPV (Nylund
et al. 2008; Gjessing et al. 2017, 2019; Garseth et al.
2018; Downes et al. 2018a). See Table 1.
Little is known about risk factors for epitheliocystis. High
stocking densities and high nutrient levels in the water may
affect presence (Woo & Bruno 2014). It has been suggested
that the season might be important, but neither water salin-
ity nor age of the fish appear to be risk factors (Nowak &
Clark 1999). Cleaner fish of the species Centrolabrus exole-
tus, Ctenolabrus rupestris, Labrus bergylta, L. mixtus and
Symphodus melops from the west coast of Norway have
been found with epitheliocyst-forming Chlamydia on the
gills, which could mean they act as vectors or reservoir
hosts (Steigen et al. 2018). However, the Chlamydiae
observed from the cleaner fish were not detected in salmo-
nids, and it has been suggested that they might not affect
salmon (Steigen et al. 2018).
Tenacibaculosis/flexibacteriosis
This salt water ulcerative disease has been given many dif-
ferent names, such as ‘salt water columnaris disease’, ‘glid-
ing bacterial disease of sea fish’, ‘bacterial stomatitis’,
‘eroded mouth syndrome’ and ‘black patch necrosis’ (re-
viewed by Avenda~no-Herrera et al. (2006b)). This Gram-
negative filamentous bacterium responsible for the disease
is currently known as Tenacibaculum maritimum, after hav-
ing previously been described as Flexibacter marinus, Flex-
ibacter maritimus and Cytophaga marina (reviewed by
Suzuki et al. (2001) and Avenda~no-Herrera et al. (2006b)).
T. maritimum is an opportunistic bacterium that is com-
monly found on gill tissue of both healthy and diseased fish
(Fringuelli et al. 2012). Though high levels were associated
with gill disease (Ruane et al. 2013), it is unknown whether
this association implies causality of T. maritimum for gill
disease, the other way around, or an entirely different type
of association. Gills might not be the most important route
for infection of this opportunistic pathogen as it also affects
other organs (Avenda~no-Herrera et al. 2006b). The patho-
gen has been reported in many different fish species in
Japan, Europe, Australia, USA, Chile and Canada, and for
reviews see Toranzo et al. (2005), Avenda~no-Herrera et al.
(2006b) and Frisch et al. (2017). Other Tenacibaculum spp.
have been identified as salmonid pathogens that cause simi-
lar disease symptoms, including as T. finnmarkense (Smage
et al. 2016a, 2017) and T. dicentrarchi (Avenda~no-Herrera
et al. 2016). It has been suggested multiple Tenacibaculum
spp. colonise the surface of Atlantic salmon (Karlsen et al.
2017).
Fish infected with T. maritimum may be lethargic, anor-
exic (Handlinger et al. 1997) and have an increased respira-
tory rate. They can have erosions and haemorrhages within
and around the oral cavity, scale loss, ulcerative skin
lesions, frayed fins and tail rot. A typical yellow margin
might be present around these lesions (Smage et al. 2017),
see Figure 3, which can be the portal of entry for other bac-
terial or parasitic agents (Toranzo et al. 2005). Lesions in
the gills, which are not always present, can consist of focal
areas of necrosis, and erosion in connective tissue associ-
ated with filamentous bacterial mats on lamellae, which
looks like ‘gill rot’. Free ends of one to several primary
lamellae can be eroded. Gills may have increased mucus, or
an acute inflammation, which could indicate another
insult, such as jellyfish exposure (Handlinger et al. 1997;
Mitchell & Rodger 2011). Tenacibaculum may also be
involved in the pathogenesis of ‘winter ulcers’, a condition
of which Moritella viscosa is considered an important factor
(Olsen et al. 2011).
Risk factors for tenacibaculosis are high water tempera-
tures, usually over 15°C (Toranzo et al. 2005; Downes et al.
2018a), but possibly lower, depending on the bacterial
strain (Frisch et al. 2017). The bacteria often colonise
epithelia secondary to other insults, such as infection with
D. lepeophtherii (Weli et al. 2017) or injuries caused by
harmful zooplankton and jellyfish (Rodger et al. 2011a).
Younger fish are at greater risk (Toranzo et al. 2005). T.
maritimum is usually outcompeted in seawater by other
bacterial species and might need to remain attached to a
substrate or animal surface (Avenda~no-Herrera et al.
2006a). Such a substrate might be a host or vector for this
bacteria, such as the jellyfish species Phialella quadrata
(Ferguson et al. 2010), P. noctiluca (Delannoy et al. 2011)
and Muggiaea atlantica (Fringuelli et al. 2012), the sea louse
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Lepeophtheirus salmonis (Barker et al. 2009), and the cleaner
fish Cyclopterus lumpus L (Smage et al. 2016b). Other risk
factors include high salinities, stress, elevated ammonia and
physical or toxic insults (Mitchell & Rodger 2011). In a
study in Norway, recently transferred smolts were more
affected by tenacibaculosis than smolts that had been in the
salt water longer (Smage et al. 2017). This may be because
smolts that have just transferred to salt water have reduced
resilience due to changes in their microbiota as a result of
the change in conditions (Lokesh & Kiron 2016), pressure
on osmoregulatory control and elevated stress levels as a
result of the transfer process (Iversen et al. 2005).
Definitive diagnosis can be based on microbiological
methods (Toranzo et al. 2005), and on PCR (Avenda~no-
Herrera et al. 2006b; Fringuelli et al. 2012). Treatment
is through antibiotics (Morrison & Saksida 2013),
improved environment or removal of the primary stressor
or insult.
The presence of T. maritimum could not be statistically
associated with increased gill scores (Fringuelli et al. 2012).
It has been observed simultaneously with epitheliocysts
(Rodger et al. 2011b; Downes et al. 2018a), the parasites
Ichthyobodo spp, Trichodina, D. lepeophtherii (Rodger et al.
2011b; Downes et al. 2018a), the virus SGPV (Downes et al.
2018a) and jellyfish (Ferguson et al. 2010; Delannoy et al.
2011; Rodger et al. 2011b; Ruane et al. 2013; Marcos-Lopez
et al. 2016). T. maritimum was observed simultaneously
with N. perurans (Powell et al. 2005; Rodger et al. 2011b;
Downes et al. 2018a), but there was no evidence of interac-
tions between them (Powell et al. 2005). See Table 1.
For a review, see Avenda~no-Herrera et al. (2006b).
Zooplankton (cnidarian nematocyst)-associated gill
disease
Gelatinous zooplankton (referred to hereafter as jellyfish)
occur in oceans worldwide and can be associated with high
mortality rates in open-pen salmonid aquaculture. Exam-
ples include a study in Ireland in which 70% of mortality of
all fish was due to occasional bloom events (Ruane et al.
2013; Marcos-Lopez et al. 2016), and a study in Scotland
which found that around 60% of all fish mortalities due to
plankton between 1999 and 2005 were associated with jelly-
fish (Scottish Government 2018a). Jellyfish abundance has
been correlated to daily mortality rates with a lag of one to
seven days (Baxter et al. 2011a), and blooms can lead to
increased operational cost and insurance fees (Lucas et al.
2014).
Most zooplankton-associated gill disease is due to stings
of free-living jellyfish. Cnidarian jellyfish have stinging cells
which contain nematocysts that can cause mechanical and
toxic insults to the fish gills and epithelia (Marcos-Lopez
et al. 2016). In open net pens such as used in salmon aqua-
culture, small and transparent cnidarian jellyfish enter the
fish pens intact, whereas larger jellyfish are broken up
against the net mesh (Marcos-Lopez et al. 2016). Both of
these cases can lead to nematocyst damage. Additionally,
avoidance behaviour of the fish, such as excessive jumping,
may result in more mechanical damage (Bamstedt et al.
1998). It has been proposed that jellyfish may serve as reser-
voirs or vectors for pathogens such as Tenacibaculum spp.
(Ferguson et al. 2010; Fringuelli et al. 2012; Smage et al.
2017), which can cause disease in the fish.
Sessile jellyfish, hydrozoans, can foul aquaculture struc-
tures so that water flow and quality is reduced. To counter
this, nets can be cleaned using pressure washers, but fish in
cages have been observed to exhibit avoidance behaviour
from the dense clouds of debris that come off the nets dur-
ing the cleaning process. Experimental challenges showed
that this debris can cause pathological changes in the gills,
such as epithelial sloughing, necrosis and haemorrhaging
(Baxter et al. 2012; Bloecher et al. 2018).
Clinical signs associated with presence of or damage
caused by jellyfish include lethargic behaviour, fish swim-
ming high in the water column close to the water surface
and increased jumping behaviour (Marcos-Lopez et al.
2016). Sometimes zooplankton can still be seen in the gills
both macroscopically and microscopically. Macroscopic
signs include skin erosions, scale loss, swollen or haemor-
rhagic lesions on the skin with ulcers, see Figure 3. Micro-
scopically, the gill damage observed can consist of
hyperplasia, lamellar fusion, occasional presence of giant
cells and bullae-like formations at the edges of filaments in
chronic lesions with necrosis, haemorrhages, congestion,
Figure 3 Zooplankton damage from Muggiaea atlantica with erosion
of gill rakers and Tenacibaculum sp. colonisation of damaged tissue
obvious as yellowish colouration on damaged tissue.
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infiltration, oedema, lamellar epithelium sloughing and loss
of tissue inflammation (Baxter et al. 2011a, 2011b; Ruane
et al. 2013; Marcos-Lopez et al. 2016). Microscopic and/or
macroscopic signs are not always observed during a jellyfish
bloom (Smage et al. 2017). A yellow-brown colour associ-
ated with skin and gill lesions from jellyfish could indicate
aggregations of Tenacibaculum sp. (Rodger et al. 2011a;
Marcos-Lopez et al. 2016).
Risk factors for jellyfish blooms are warm weather (Mar-
cos-Lopez et al. 2016), and there is some evidence that pro-
cesses like overfishing, eutrophication, climate change,
translocations and habitat modification may lead to more
jellyfish blooms (Richardson et al. 2009). Fish have been
treated with antibiotic, such as oxytretracycline in some
cases in the past, after a jellyfish encounter to reduce the
impact of secondary bacterial infections (Marcos-Lopez
et al. 2016).
Jellyfish damage has been observed simultaneously with
T. maritimum (Ferguson et al. 2010; Delannoy et al. 2011;
Rodger et al. 2011b; Ruane et al. 2013; Marcos-Lopez et al.
2016) and T. finmarkense (Smage et al. 2017). See Table 1.
For a review on this topic, see Purcell et al. (2013).
Harmful algal gill disease
Many species of phytoplankton occur in fresh and salt
water. Any phytoplankton species that may have a dele-
terious effect on other aquatic species or humans (in-
cluding economic damage) is referred to as harmful
(Kralberg et al. 2010). Harmful algae blooms (HABs)
have been responsible for gill damage and salmon mor-
tality around the world (Rodger et al. 2011a). Several
mechanisms can lead to gill damage and mortality. Clog-
ging and abrasion of gill structures can lead to excessive
mucus production, which can lead to oxygen deprivation
and thus suffocation of the fish (Bruno et al. 1989; Kent
et al. 1995). Photosynthesis and respiration of phyto-
plankton populations associated with HABs can lead to
both oxygen depletion and oxygen supersaturation dur-
ing a major bloom event (Jones & Rhodes 1994; Hishida
et al. 1998). Toxins produced by algae can cause damage
to gills or other organs and cause morbidity and mortal-
ity (Chang et al. 1990). Lastly, phytoplankton may attach
to benthic substrate and cause increased biofouling
(Kaatvedt et al. 1991). Clinical signs of HABs are
decreased feeding rate, avoidance behaviour such as
maintaining a particular position in the water column
and respiratory distress behaviour such as gasping at the
surface, increased ventilatory effort and respiration rate
and gathering in areas of higher oxygen like facing into
the incoming current (Treasurer et al. 2003; Rodger
et al. 2011a). Furthermore, irritation of the gills due to
HABs can lead to bleeding gills, petechiae on gills and
increased mucus production on the gills (Rodger et al.
2011a).
Associated pathology in gills depends on the type of
interaction between the different algae species and gill tis-
sue. It includes severe necrosis and sloughing with separa-
tion of secondary gill lamellae and hyperplasia (Bruno et al.
1989). There can also be oedema at the base of the sec-
ondary lamellae, inflammation (Kent et al. 1995) and vas-
cular changes (Chang et al. 1990). Other organs, such as
the liver, can also be affected (Treasurer et al. 2003; Mitch-
ell & Rodger 2007).
Mitigation methods against HABs have been reviewed by
Rensel and Whyte (2004) and include adjusting feeding
and other husbandry practices during the bloom, airlift
pumping of deep water into the cages, oxygenation and
aeration, moving or submerging cages, using alternatives to
seawater cages such as onshore tanks, treating the water
(e.g. through adding clay), using live cage bioassays nearby
a production site as early indicators and to test virulence of
HABs, early harvest and using freshwater to lower salinity
and reduce energy costs of osmoregulation.
For reviews, see Rensel and Whyte (2004) and Rodger
et al. (2011a).
Chemical/toxin-associated gill disease
Eutrophication around coastal areas can lead to an increase
of harmful compounds in the water, for example (waste)
products of forestry, agriculture, industry or sewage sys-
tems (Rodger et al. 2011a). Very little is known about the
effect of such compounds on fish gills in salt water, which
may be different to the effects on gills of fish in fresh water
(Mallatt 1985). Also chemicals from treatments, such as
hydrogen peroxide, may affect gills (Kiemer & Black 1997;
Adams et al. 2012). The effects that water quality in fresh-
water has on the marine survival of salmon remains to be
determined for many parameters, metals and chemicals
such as pH, carbon dioxide and formalin (Kroglund et al.
2007).
Discussion and Conclusions
An increase in prevalence of marine gill disease and associ-
ated financial losses led to an increase in research on puta-
tive aetiological factors of CGD over the last decade. This
resulted in an increase in monitoring, mapping and our
understanding of marine gill diseases, but has not led to a
full understanding of the role of the different putative com-
ponents of the aetiology of CGD.
Complex gill disease is frequently associated with multi-
ple putative pathogens. Table 1 lists pairs of putative patho-
gens that occurred simultaneously, and more often than
not more than two pathogens occur in one sample. In
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addition, perhaps the aetiology of CGD involves more than
these putative pathogens and is similar to other multifacto-
rial diseases where disease response is not only determined
by infectious agents, but also by synergic effects between
infectious agents, environment, management and the
immune status of the animals (Lorenz et al. 2011; Herrero
et al. 2018). An example of a possible complex association
between CGD and management is the employment of clea-
ner fish to control sea lice, which requires a smaller mesh
size (Kent 1992), which may in turn affect abundance, spe-
cies richness, and species composition of biofouling organ-
isms (Bloecher et al. 2018), which in turn may affect gill
health. In future studies of CGD, it is therefore important
to not only investigate the relation between CGD and puta-
tive aetiological agents, but also between CGD and other
factors such as management strategies and interactions
between the different putative components of the aetiology
of CGD.
Areas for continued study
Studying the transmission of putative pathogens between
fish and the effect of interactions between pathogens is a
challenge. This review and accompanying tables show that
many different pathogens may be involved with CGD, and
they occur in many different combinations. Although some
pathogens listed may not be primary pathogens, they may
exacerbate CGD. Controlled laboratory trials with these
putative pathogens are currently not possible, because most
of the pathogens have not been cultured successfully. An
uncontrolled laboratory trial, such as described in a study
by Wiik-Nielsen et al. (2017) in which freshwater salmon
that were naturally infected with putative pathogens for
CGD in the field and were imported into the laboratory
and used in cohabitation experiments may currently be the
only way to study transmission of putative pathogens.
However, this method cannot be standardised as there is
no control over infection levels and types of putative patho-
gens in the infected fish imported from a field situation. It
may therefore on the one hand be important to identify key
players in the aetiology of CGD and develop systems that
allow for controlled trials, but on the other hand consider-
ing the system as a black box and focusing on mitigation of
risk factors in farm management systems.
One of the key challenges in any study of CGD is the
need for a clear case definition. The different terms that
have been used to describe marine gill disease have led to
confusion and make it difficult to compare between studies
and areas. CGD as currently used, includes most other
pathologies (Herrero et al. 2018; Noguera et al. 2019), but
its boundaries are not well defined. A clear case definition
would allow for a systematic estimation of prevalences
across the salmon industry in different areas and countries
and could aid epidemiological studies such as risk-factor
analyses.
There is a need for comprehensive epidemiological stud-
ies that take into account the different putative components
of CGD. Research regarding individual components, such
as putative pathogens and environmental factors, has pro-
vided increased knowledge and understand of their associa-
tions with marine gill disease. With this knowledge came
awareness and increased surveillance for putative compo-
nents for CGD. As a result of this knowledge and increased
monitoring, a next step may be to attempt understanding
the possibly complex interactions between such compo-
nents. Two such studies were launched in 2018, when sal-
mon producers in Scotland and Norway engaged in
industry wide, inclusive epidemiological projects on marine
gill health in farmed salmon (FHF 2019; SAIC 2019).
It is unclear why CGD has emerged as a significant health
problem, as many of the putative pathogens associated with
CGD have been shown to be present for years retrospec-
tively. The answer may lay in other components that may
be part of a multifactorial aetiology for CGD, which have
changed over the last decade. For example, the industry
saw many changes in management strategies stimulated by
the need to be sustainable and profitable, such as further
intensification, changes in diet ingredients, changes in
genetic factors (Ellis et al. 2016) and technological advances
(Føre et al. 2018). Also, natural processes, such as the cli-
mate, have not remained constant, and temperatures have
been rising. As a result of changes occurring simultaneously
in the different putative components for CGD, it is chal-
lenging to retrospectively pinpoint why CGD has emerged
as a significant fish health problem.
Looking to the future, it may not be possible to eliminate
CGD entirely, similar to the current state of sea lice and
AGD. Mitigation efforts may need to focus on control of
CGD to proportions that are acceptable from both an ani-
mal welfare and animal production standpoint. Current
research efforts are improving our knowledge and may help
to better understand CGD.
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